Cipla on Wednesday said its arm Goldencross Pharma Pvt Ltd has entered into an agreement to sell its 100 per cent stake in Four M Propack to Shriji Polymers for ₹19.20 crore. The transaction is expected to be completed within 45 days, Cipla said. The total consideration includes a sum derived from mutual funds, cash and bank balances, and tax funds, among others, estimated at ₹5.7 crore, the drug major said to the exchanges.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.